Zobrazeno 1 - 8
of 8
pro vyhledávání: '"N. M. Nasybullina"'
Autor:
N. M. Nasybullina
Publikováno v:
Pharmaceutical Chemistry Journal. 33:88-93
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8a8eeffcd63f60c9dceb6d8074a8e24
https://doi.org/10.1007/bf02508115
https://doi.org/10.1007/bf02508115
Autor:
N. M. Nasybullina
Publikováno v:
ChemInform. 30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d8c8d11755a637f7451b967877a8524
https://doi.org/10.1002/chin.199922298
https://doi.org/10.1002/chin.199922298
Publikováno v:
Pharmaceutical Chemistry Journal. 32:290-292
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77a872b96546b54a98dce6f421cb341a
https://doi.org/10.1007/bf02580509
https://doi.org/10.1007/bf02580509
Publikováno v:
Pharmaceutical Chemistry Journal. 31:391-393
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb9c7bfd36222c2f320bfe09dc9d8d6d
https://doi.org/10.1007/bf02464346
https://doi.org/10.1007/bf02464346
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 60(6)
The authors studied the permeability of the blood-brain barrier (CEB) to two nootropics: calcium ketogomopantothenate (KRA-Ca), a GABA derivative, and and calcium salt of oxybutyrate (OB-Ca), a derivative of GOBA. It was established that both prepara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ba3dc7cb222b60daa99c39f44697bc4f
https://pubmed.ncbi.nlm.nih.gov/9460601
https://pubmed.ncbi.nlm.nih.gov/9460601
Autor:
N M, Nasybullina, V I, Gunar, V P, Zherdev, A K, Sariev, G S, Kozlova, R S, Mirzoian, T S, Gan'shina, A L, Karaev
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 60(2)
The permeability through the blood-brain barrier of N-(4-hydroxy-3,3 dimethyl-2-oxo-1-butiryl) gamma-aminobutyric acid calcium salt, a new neurotropic drug calcium ketohomopantothenate (KPA-Ca), was studied in comparison with that of calcium homopant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a5b880d3d0573aaa70e8ee74a80508e
https://pubmed.ncbi.nlm.nih.gov/9206573
https://pubmed.ncbi.nlm.nih.gov/9206573
Publikováno v:
Pharmaceutical Chemistry Journal. 30:737-738
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4d37730a68171613be7b80e0ac62e6f
https://doi.org/10.1007/bf02218823
https://doi.org/10.1007/bf02218823
Autor:
A. I. Artemiev, M. M. Astrakhanova, K. V. Alekseev, G. S. Kiseleva, N. V. Anikina, I. A. Elagina, N. M. Nasybullina, L. A. Prikhodko, L. V. Sollogub, Yu. G/ Truckman, U. H. Usmanov, R. A. Abramovich, M. K. Ordzhonikidze
Publikováno v:
Kazan medical journal. 76:269-270
One of the main directions of scientific research of the Research Institute of Pharmacy is the development of new effective medicines in the form of various solutions, ointments, suppositories, tablets, granules, powders, extracts intended for the tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3130923f7eeb9bc0efe70cce637edd9
https://doi.org/10.17816/kazmj101001
https://doi.org/10.17816/kazmj101001